Genomic and Transcriptomic Predictors of Sequential SG Sensitivity After T-DXd in ER+/HER2-Low Metastatic Breast Cancer
- First Posted Date
- 2024-10-30
- Last Posted Date
- 2024-10-30
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 20
- Registration Number
- NCT06665178
- Locations
- 🇨🇦
BC Cancer - Vancouver Center, Vancouver, British Columbia, Canada
NEoadjuvant Olaparib Combination OvArian Cancer Targeted Study
Phase 2
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-10-21
- Last Posted Date
- 2024-10-23
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 40
- Registration Number
- NCT06650709
Improving Detection of Early Lung Cancer in a Diverse Population (IDEAL) Study
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-10-04
- Last Posted Date
- 2024-10-04
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 3600
- Registration Number
- NCT06628102
- Locations
- 🇨🇦
BC Cancer Research, part of the Provincial Health Authority, Vancouver, British Columbia, Canada
Using Tumour DNA and Proteins to Better Understand How Pancreatic Cancer Responds to Treatment
- First Posted Date
- 2024-08-28
- Last Posted Date
- 2024-10-04
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 200
- Registration Number
- NCT06574620
- Locations
- 🇨🇦
BC Cancer, Vancouver, British Columbia, Canada
Evidence Development in Cancer Treatment - Real World: PREDiCTrw
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-02-05
- Last Posted Date
- 2024-10-04
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 100
- Registration Number
- NCT06242912
- Locations
- 🇨🇦
BC Cancer, Vancouver, British Columbia, Canada
Diagnostic CT Palliative Radiotherapy: Feasibility Study of Treating Bone Metastases Without a CT Simulation
- First Posted Date
- 2024-01-31
- Last Posted Date
- 2024-01-31
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 10
- Registration Number
- NCT06235034
Preliminary Assessment of [18F]BL40 in PET/CT Scans
- First Posted Date
- 2024-01-25
- Last Posted Date
- 2024-02-09
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 30
- Registration Number
- NCT06224309
- Locations
- 🇨🇦
BC Cancer, Vancouver, British Columbia, Canada
CLIC-2201 for the Treatment of Relapsed/Refractory B Cell Malignancies
- First Posted Date
- 2024-01-17
- Last Posted Date
- 2024-10-18
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 24
- Registration Number
- NCT06208735
- Locations
- 🇨🇦
Alberta Children's Hospital, Calgary, Alberta, Canada
🇨🇦Calgary Cancer Centre, Calgary, Alberta, Canada
🇨🇦Vancouver General Hospital, Vancouver, British Columbia, Canada
Multi-omic Approach to Study HDR Brachytherapy for Favorable Risk and Low Tier Intermediate Risk Prostate Cancer
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-01-11
- Last Posted Date
- 2024-04-15
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 100
- Registration Number
- NCT06200974
- Locations
- 🇨🇦
British Columbia Cancer Center for the Southern Interior, Kelowna, British Columbia, Canada
Single vs. Multiple Fraction Trial of Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastases/Progression
Not Applicable
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-03-24
- Last Posted Date
- 2024-01-23
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 598
- Registration Number
- NCT05784428
- Locations
- 🇨🇦
BC Cancer, Vancouver, British Columbia, Canada
🇨🇦BC Cancer - Victoria, Victoria, British Columbia, Canada
© Copyright 2024. All Rights Reserved by MedPath